148 related articles for article (PubMed ID: 26835221)
1. Alcohol and breast cancer tumor subtypes in a Spanish Cohort.
Gago-Dominguez M; Castelao JE; Gude F; Fernandez MP; Aguado-Barrera ME; Ponte SM; Redondo CM; Castelo ME; Dominguez AN; Garzón VM; Carracedo A; Martínez ME
Springerplus; 2016; 5():39. PubMed ID: 26835221
[TBL] [Abstract][Full Text] [Related]
2. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
3. First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.
Elidrissi Errahhali M; Elidrissi Errahhali M; Ouarzane M; El Harroudi T; Afqir S; Bellaoui M
BMC Womens Health; 2017 Jan; 17(1):3. PubMed ID: 28068979
[TBL] [Abstract][Full Text] [Related]
4. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
5. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
[TBL] [Abstract][Full Text] [Related]
6. LIPG endothelial lipase and breast cancer risk by subtypes.
Gago-Dominguez M; Redondo CM; Calaza M; Matabuena M; Bermudez MA; Perez-Fernandez R; Torres-Español M; Carracedo Á; Castelao JE
Sci Rep; 2021 May; 11(1):10436. PubMed ID: 34001944
[TBL] [Abstract][Full Text] [Related]
7. Alcohol, Physical Activity, Smoking, and Breast Cancer Subtypes in a Large, Nested Case-Control Study from the Norwegian Breast Cancer Screening Program.
Ellingjord-Dale M; Vos L; Hjerkind KV; Hjartåker A; Russnes HG; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1736-1744. PubMed ID: 28877889
[No Abstract] [Full Text] [Related]
8. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW
Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043
[TBL] [Abstract][Full Text] [Related]
10. Alcohol consumption and risk of breast cancer by molecular subtype: Prospective analysis of the nurses' health study after 26 years of follow-up.
Hirko KA; Chen WY; Willett WC; Rosner BA; Hankinson SE; Beck AH; Tamimi RM; Eliassen AH
Int J Cancer; 2016 Mar; 138(5):1094-101. PubMed ID: 26384849
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis.
Liu JB; Feng CY; Deng M; Ge DF; Liu DC; Mi JQ; Feng XS
World J Surg Oncol; 2017 Aug; 15(1):139. PubMed ID: 28764784
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for breast cancer and their association with molecular subtypes in a population of Northeast Brazil.
Gomes KAL; de Araújo Jerônimo AF; Guimarães CMC; de Oliveira Ramos R; Dos Santos Andrade LS; Weller M
Cancer Epidemiol; 2022 Jun; 78():102166. PubMed ID: 35486969
[TBL] [Abstract][Full Text] [Related]
13. Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.
Cancello G; Maisonneuve P; Rotmensz N; Viale G; Mastropasqua MG; Pruneri G; Montagna E; Dellapasqua S; Iorfida M; Cardillo A; Veronesi P; Luini A; Intra M; Gentilini O; Scarano E; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2011 Jun; 127(3):713-20. PubMed ID: 21452022
[TBL] [Abstract][Full Text] [Related]
14. No association between triple-negative breast cancer and prognosis of patients receiving breast-conserving treatment.
Mu L; Liu Y; Xiao M; Liu W; Liu M; Wang X
Oncol Lett; 2017 Dec; 14(6):7862-7872. PubMed ID: 29250179
[TBL] [Abstract][Full Text] [Related]
15. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
16. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Pathological Characteristics of Triple Positive Breast Cancer among Iraqi Patients.
Alwan NAS; Mualla FH; Al Naqash M; Kathum S; Tawfiq FN; Nadhir S
Gulf J Oncolog; 2017 Sep; 1(25):51-60. PubMed ID: 29019331
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
19. Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.
Prat A; Brase JC; Cheng Y; Nuciforo P; Paré L; Pascual T; Martínez D; Galván P; Vidal M; Adamo B; Hortobagyi GN; Baselga J; Ciruelos E
Oncologist; 2019 Jul; 24(7):893-900. PubMed ID: 30679318
[TBL] [Abstract][Full Text] [Related]
20. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]